Clinical trial
Nebivolol in Patients With Systolic Stage 2 Hypertension
NCT01057251
Study timeline
Study start (unknown)2010-03-01Date precision: month
Registry last updated2012-01-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypertensionunresolved
Interventions
NebivololDRUG · verified · RxNorm: nebivolol
PlaceboDRUG
Sponsors & collaborators
Forest Laboratorieslead sponsor
Mapped research locations
BaltimoreMaryland, United States2MiamiFlorida, United States2Fort LauderdaleFlorida, United States2New YorkNew York, United States1Los AngelesCalifornia, United States1AtlantaGeorgia, United States1JacksonvilleFlorida, United States1OrlandoFlorida, United States1Las VegasNevada, United States1CharlestonSouth Carolina, United States1RichmondVirginia, United States1MemphisTennessee, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01057251 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.